Form D · Biotechnology

NEOVASC INC

Richmond, A1 · CIK 0001399708

Offering snapshot reported Mar 24, 2011 · SEC filing

Reported sold
$26.2K
Offering amount: $26.2K
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Mar 16, 2011
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 24, 2011Initial$26,215No comparison1SEC filing
May 4, 2009Initial$1,503,010No comparisonNot reportedSEC filing
Aug 1, 2008PaperNot reportedNo comparisonNot reportedSEC filing
Jul 21, 2008PaperNot reportedNo comparisonNot reportedSEC filing
May 8, 2007PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-157247
13(a) represents the price of the options exercised (65,000 options @ C$0.40), converted to US$ based on the exchange rate on the date of exercise, March 16, 2011, of US$1.00=C$0.9918.

Source: Form D, filed Mar 24, 2011. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Chris Clark Executive
Paul Geyer Director
Jane Hsiao Director
Douglas Janzen Director
Doug Janzen Director
Efrem Kamen Director
Boaz Lifschitz Director
Alexei Marko Director, Executive
Brian Mcpherson Executive
William O'neill Director
Steven Rubin Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
2135 13700 Mayfield Place
Richmond, A1, 00000